| Literature DB >> 19267375 |
Martin Hintersteiner1, Thierry Kimmerlin, Geraldine Garavel, Thorsten Schindler, Roman Bauer, Nicole-Claudia Meisner, Jan-Marcus Seifert, Volker Uhl, Manfred Auer.
Abstract
New and improved: The incorporation of a 6-chlorotryptophan (6-Cl-Trp) into a beta-peptide (M)-3(14) helix leads to a high-affinity hDM2 inhibitor, as demonstrated by fluorescence fluctuation analysis at single molecule resolution. When conjugated to penetratin, the newly derived hDM2 binder specifically inhibits tumour cell growth in vitro.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19267375 DOI: 10.1002/cbic.200800803
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164